Effect of sulfonylureas on switching to insulin therapy (twice-daily biphasic insulin aspart 30): Comparison of twice-daily biphasic insulin aspart 30 with or without glimepiride in type 2 diabetic patients poorly controlled with sub-maximal glimepiride

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Safety and effectiveness of biphasic insulin aspart 30 in a Bangladeshi subgroup of type 2 diabetic patients switched from biphasic human insulin 30: A sub-analysis of the A1chieve study

Diabetes Research and Clinical Practice ◽

10.1016/s0168-8227(13)70007-x ◽

2013 ◽

Vol 100 ◽

pp. S30-S34 ◽

Cited By ~ 2

Author(s):

Zafar Ahmed Latif ◽

Md. Faruque Pathan ◽

Md. Nazrul Islam Siddiqui ◽

Md. Javed Sobhan ◽

Md. Mahfuzur Rahman ◽

...

Keyword(s):

Human Insulin ◽

Insulin Aspart ◽

Diabetic Patients ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Six-month multicentric, open-label, randomized trial of twice-daily injections of biphasic insulin aspart 30 versus multiple daily injections of insulin aspart in Japanese type 2 diabetic patients (JDDM 11)

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2007.08.011 ◽

2008 ◽

Vol 79 (1) ◽

pp. 171-176 ◽

Cited By ~ 32

Author(s):

Koichi Hirao ◽

Keiko Arai ◽

Mikio Yamauchi ◽

Hirofumi Takagi ◽

Masashi Kobayashi

Keyword(s):

Randomized Trial ◽

Insulin Aspart ◽

Diabetic Patients ◽

Open Label ◽

Multiple Daily Injections ◽

Biphasic Insulin ◽

Attainment of glycaemic goals by step-up therapy with biphasic insulin aspart-70/30 in Japanese type 2 diabetic patients

Endocrine Journal ◽

10.1507/endocrj.k10e-307 ◽

2011 ◽

Vol 58 (2) ◽

pp. 131-135 ◽

Cited By ~ 5

Author(s):

Yasuhiro Hosoi ◽

Ken-Ichi Ohtani ◽

Hiroyuki Shimizu ◽

Kouji Kashima ◽

Noriyuki Sato ◽

...

Keyword(s):

Insulin Aspart ◽

Diabetic Patients ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic patients receiving biphasic insulin aspart 30 or biphasic human insulin 30

Journal of Diabetes Investigation ◽

10.1111/j.2040-1124.2011.00123.x ◽

2011 ◽

Vol 2 (5) ◽

pp. 406-411 ◽

Cited By ~ 2

Author(s):

Akio Ohta ◽

Tomoko Suwa ◽

Yoshiyuki Sada ◽

Hiroyuki Kato ◽

Rieko Koganei ◽

...

Keyword(s):

Human Insulin ◽

Continuous Glucose Monitoring ◽

Insulin Aspart ◽

Glucose Monitoring ◽

Diabetic Patients ◽

Biphasic Insulin ◽

DB3 DECREASED RATES OF MAJOR HYPOGLYCAEMIC EVENTS LEAD TO IMPROVED LONG TERM COST EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30/70 VERSUS BIPHASIC HUMAN INSULIN 30 IN TYPE 2 DIABETIC SUBJECTS IN DANISH, FINNISH, GERMAN, NORWEGIAN, SPANISH, SWEDISH, AND UK SETTINGS

Value in Health ◽

10.1016/s1098-3015(10)65672-0 ◽

2004 ◽

Vol 7 (6) ◽

pp. 649 ◽

Cited By ~ 3

Author(s):

M Lammert ◽

AJ Palmer ◽

S Roze ◽

ME Minshall ◽

WJ Valentine

Keyword(s):

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Sustainable Glycemic Control with Combination Insulin Therapy (Biphasic Insulin Plus Rapid-Acting Insulin) Mimicking Physiologic Insulin Secretion in Type 2 Diabetic Patients

10.1210/endo-meetings.2011.part2.p10.p1-536 ◽

2011 ◽

pp. P1-536-P1-536

Author(s):

Nestor Eric Ruiz Laplano ◽

Leilani Mercado Asis

Keyword(s):

Insulin Secretion ◽

Glycemic Control ◽

Insulin Therapy ◽

Diabetic Patients ◽

Biphasic Insulin ◽

Acting Insulin ◽

Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix®30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE™ observational study

International Journal of Clinical Practice ◽

10.1111/j.1742-1241.2009.02002.x ◽

2009 ◽

Vol 63 (3) ◽

pp. 522-531 ◽

Cited By ~ 50

Author(s):

P. Valensi ◽

M. Benroubi ◽

V. Borzi ◽

J. Gumprecht ◽

R. Kawamori ◽

...

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Insulin Therapy ◽

Insulin Aspart ◽

Routine Care ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Starting Insulin Therapy in Type 2 Diabetes: Twice-Daily Biphasic Insulin Aspart 30 Plus Metformin versus Once-Daily Insulin Glargine Plus Glimepiride

Experimental and Clinical Endocrinology & Diabetes ◽

10.1055/s-2006-949655 ◽

2006 ◽

Vol 114 (09) ◽

pp. 527-532 ◽

Cited By ~ 76

Author(s):

P. Kann ◽

T. Wascher ◽

V. Zackova ◽

J. Moeller ◽

J. Medding ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Therapy ◽

Insulin Aspart ◽

Once Daily ◽

Daily Insulin ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy

Clinical Therapeutics ◽

10.1016/s0149-2918(03)90095-6 ◽

2003 ◽

Vol 25 (12) ◽

pp. 3109-3123 ◽

Cited By ~ 17

Author(s):

Itamar Raz ◽

Ulrik Mouritzen ◽

Julius Vaz ◽

Tommy Hershkovitz ◽

Julio Wainstein ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

PDB24 COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO BIPHASIC INSULIN ASPART 30 FROM BIPHASIC HUMAN INSULIN 30 IN THE CZECH SETTING

Value in Health ◽

10.1016/s1098-3015(10)75002-6 ◽

2009 ◽

Vol 12 (7) ◽

pp. A405-A406

Author(s):

E Suchankova ◽

T Doležal ◽

Z Pisarikova ◽

K Rychna ◽

D Bartaskova

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

Cost Effectiveness Analysis ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Effectiveness Analysis ◽